Botox therapy for refractory chronic migraine

被引：20
|
作者：
Conway, S [1 ]
Delplanche, C [1 ]
Crowder, J [1 ]
Rothrock, J [1 ]
机构：
[1] Univ S Alabama, Headache Ctr, Mobile, AL 36693 USA
来源：
HEADACHE | 2005年 / 45卷 / 04期
关键词：
chronic migraine; botulinum toxin type A; BOTOX;
D O I：
10.1111/j.1526-4610.2005.05073a.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Chronic migraine is unfortunately both common and often resistant to treatment even with prophylactic medications known to be effective in populations with episodic migraine. We undertook an open-label study to evaluate the safety and utility of botulinum toxin type A injection therapy for patients with chronic migraine who previously had failed to respond to at least three prophylactic medications.
引用
收藏
页码：355 / 357
页数：3
相关论文
共 50 条
  • [21] Emerging treatment for chronic migraine and refractory chronic migraine
    Lionetto, Luana
    Negro, Andrea
    Palmisani, Stefano
    Gentile, Giovanna
    Del Fiore, Maria Rosaria
    Mercieri, Marco
    Simmaco, Maurizio
    Smith, Thomas
    Al-Kaisy, Adnan
    Arcioni, Roberto
    Martelletti, Paolo
    EXPERT OPINION ON EMERGING DRUGS, 2012, 17 (03) : 393 - 406
  • [22] Cognitive Behavioral Therapy in Turkish Patients With Refractory Chronic Migraine
    Uluduz, Derya
    Ertem, Devrimsel Harika
    Onur, Ozge S.
    Karsidag, Cagatay
    CEPHALALGIA, 2017, 37 : 336 - 336
  • [23] Cognitive Behavioral Therapy Experience in Patients With Refractory Chronic Migraine
    Uluduz, Derya
    Ertem, Devrimsel H.
    Onur, Ozge S.
    Ozge, Aynur
    Karsidag, Cagatay
    Siva, Aksel
    CEPHALALGIA, 2017, 37 : 335 - 335
  • [24] Is Botox Right for Me: When to Assess the Efficacy of the Botox Injection for Chronic Migraine in Pediatric Population
    Goenka, Ajay
    Yu, Sarah G.
    George, Monica C.
    Chikkannaiah, Mahesh
    MacDonald, Sarah
    Stolfi, Adrienne
    Kumar, Gogi
    NEUROPEDIATRICS, 2022, 53 (05) : 344 - 350
  • [25] Is Botox right for me: When to assess the efficacy of the Botox injection for chronic migraine in pediatric population
    Yu, S. G.
    George, M.
    Goenka, A.
    HEADACHE, 2022, 62 : 150 - 150
  • [26] Refractory migraine and chronic migraine: Pathophysiological mechanisms
    Goadsby, Peter J.
    Hargreaves, Richard
    HEADACHE, 2008, 48 (06): : 799 - 804
  • [27] Licence for Botox in so-called chronic migraine Response
    Kyne, Jennifer
    LANCET, 2010, 376 (9755): : 1826 - 1826
  • [28] Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact
    Turkel, Catherine C.
    Aurora, Sheena
    Diener, Hans-Christoph
    Dodick, David W.
    Lipton, Richard B.
    Silberstein, Stephen D.
    Brin, Mitchell F.
    MEDICINE, 2023, 102 : S59 - S66
  • [29] Onabotulinum toxin A (Botox) for chronic migraine treatment: an Italian experience
    Grazzi, L.
    Usai, S.
    NEUROLOGICAL SCIENCES, 2015, 36 : S33 - S35
  • [30] Onabotulinum toxin A (Botox) for chronic migraine treatment: an Italian experience
    L. Grazzi
    S. Usai
    Neurological Sciences, 2015, 36 : 33 - 35
12345